![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 05, 2012 9:45:35 AM
After 4 years at NutraCea in various operations, quality assurance and technical services positions, Mr. Hutchison has been appointed Senior Vice President - Operations. In his new capacity, he will have management responsibility for all of NutraCea's US plant operations, quality assurance and technical services as well as operational oversight of the Company's Brazilian rice bran bio-refinery, Irgovel.
Dr. Smith joined NutraCea March 19th as Senior Vice President - Business Development. His primary responsibilities include providing technical sales support, managing third party technical sales support providers, leadership of NutraCea's research and development activities and management of the Company's intellectual property portfolio.
Mr. Hutchinson and Dr. Smith will both join NutraCea's Senior Management Committee and will co-manage NutraCea's participation in the previously announced Joint Development Agreement with DSM, which is aimed at developing technologies to enzymatically extract and concentrate protein from rice bran.
W. John Short, Chief Executive Officer of NutraCea, stated, "I am pleased to announce the promotion of David Hutchinson to SVP - Operations. Hutch has been with NutraCea for 4 years and brings a wealth of general industry and NutraCea-specific knowledge to his new responsibilities. In his new role, he will provide strong leadership and solid management continuity to our critical operational activities in both the US and Brazil."
"I am equally pleased to welcome Robert Smith to our senior management team. Robert comes to us with a wealth of product and industry-specific knowledge that will support sales activities in all areas of our business including human ingredient sales, animal nutrition sales and functional foods. Robert's deep knowledge and background in research and development make him ideally suited to head both the Technical Sales Support and R&D efforts at NutraCea."
Biographies
Mr. Hutchinson brings 18 years of edible oil processing, research and technical expertise to the company, specializing in vegetable oils such as rice bran oil and flax oil. Mr. Hutchinson most recently worked with BiOriginal Food and Science in Saskatoon, Canada, overseeing Canadian product regulatory compliance while also serving as an operations and technical consultant on flaxseed oils, marine oils and encapsulated neutraceutial products. Prior to his employment in Canada, Mr. Hutchinson was employed by Riceland Foods in Stuttgart, Arkansas where for over a decade, he specialized in rice bran oil process modifications aimed at developing new ways to isolate functional components present in rice bran and rice bran oil. Mr. Hutchinson earned a Bachelor of Science degree in Biology from Nicholls State University and served as an adjunct faculty professor for Phillips Community College in Stuttgart, Arkansas, teaching introductory Oilseed Processing and Technology.
Dr. Smith brings over 20 years' experience managing research and development programs in both academia and the private sector, and developing product and business opportunities for botanical ingredients and plant-derived molecules in the agricultural, human and animal nutrition, and pharmaceutical industries. Previously he served as Director of Business Development at HerbalScience Group, a leader in the development of evidence-based functional ingredients from botanicals. Dr. Smith has also directed research and development programs at Global Protein Products Inc. and PhycoGen Inc., and has led research projects at Dekalb Genetics, a Monsanto Company. Dr. Smith served as Research Assistant Professor at the AgBiotech Center at Rutgers University and did Post-Doctoral work in Plant Molecular Biology at the University of Missouri-Columbia. Dr. Smith holds a Doctor of Philosophy Degree in Molecular Genetics and Cell Biology and a Bachelor of Arts Degree in Biology, both from the University of Chicago.
Recent RIBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 01:15:22 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/19/2024 08:25:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2024 01:43:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:01:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 07:36:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:51:19 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:28:01 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:05:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:58:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:53:02 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:26:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:06:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:07:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 12:55:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:25:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/31/2023 09:25:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 09:22:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 09:14:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/24/2023 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:13:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:33:59 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM